Press Room

Leading patient groups representing millions of patients with chronic diseases and acute conditions are applauding the ruling today out of the U.S. Court of Appeals for the Fifth Circuit staying the U.S District Court’s remedy in Braidwood Management v. Becerra, a case which threatens coverage of U.S. Preventive Services Task Force (USPSTF) recommended preventive services without cost sharing as required under the Patient Protection and Affordable Care Act (ACA). 

The Biden Administration announced today the formal nomination of National Cancer Institute (NCI) Director Monica M. Bertagnolli, MD as the next Director of the National Institutes of Health (NIH). This role is critical to ensuring ongoing innovation in medical research, including in oncology, and Bertagnolli could not be a better choice to lead the NIH into the bold future. In addition to previously holding many professional memberships and appointments, Bertagnolli also served on the American Cancer Society (ACS)’s Board of Directors. 

Chemotherapy drugs used to treat cancer are increasingly in short supply and have returned to the list of top-five drug classes affected by shortage.

A majority (58%) of cancer patients and survivors say they would be less likely to remain current with their recommended preventive care if it came with a cost, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN).  Over half (53%) of those surveyed quantified the cost that would present such a barrier at less than $200, with more than a quarter (28%) marking their threshold at $100.  

Cigarette smoking declined from 12.5% in 2020 to 11.5% in 2021, but one in five, or 46 million, U.S. adults continues to use tobacco products in 2021 according to new data released today by the Centers for Disease Control and Prevention (CDC).

Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.   

Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.   

Last year, the U.S. Food and Drug Administration (FDA) released its proposed rules to eliminate menthol cigarettes and eliminate all flavors in cigars. Now, nearly one year later, the rules are still not final. This inaction has allowed Big Tobacco to continue targeting these products to the Black community, who consistently reports the highest prevalence of menthol cigarette use.

Today, the U.S. House of Representatives, in a 217-215 vote, passed the Limit, Save, Grow Act, advancing provisions that would greatly restrict access to affordable care and risk progress in the fight against cancer.  

ACS CAN joined 32 patient and provider groups 33 organizations applauding the Supreme Court’s decision to pause new restrictions that would have limited access to the FDA-approved drug mifepristone while litigation about the drug works its way through the courts.